-
Research and Development Status and Progress of Antibody Technology (Part Ⅱ)
Xiaomichong
July 18, 2024
Antibody-based biological therapeutic drugs have been playing an increasingly important role in biopharmaceuticals due to their strong targeting, good specificity, and significant therapeutic effects.
-
Research and Development Status and Progress of Antibody Technology (Part I)
Xiaomichong
July 18, 2024
Antibody-based biological therapeutic drugs have been playing an increasingly important role in biopharmaceuticals due to their strong targeting, good specificity, and significant therapeutic effects.
-
ProBioGen’s Growth Strategy Continues Successfully
PharmaSources
March 06, 2023
In line with this growth, three crucial positions have been filled. These appointments reflect the company's commitment to continued growth.
-
Cold Chain Market 2021 2026 - Global Overview by Component, Logistics, Technology, Temperature Type, Type, Deployment Type, Application, and Region
prnewswire
December 07, 2021
The "Cold Chain Market Research Report by Component, Logistics, Technology, Temperature Type, Type, Deployment Type, Application, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report...
-
Schrödinger, Bayer collaborate to co-develop de novo design technology to accelerate drug discovery
americanpharmaceuticalreview
January 13, 2020
Schrödinger and Bayer announced a five-year technology alliance to develop a comprehensive de novo design solution with the objective to accelerate the discovery of innovative high-quality drugs.
-
Announcement of collaborative research agreement with National Cancer Center on analy sis of gut bacteria related to cancer
biopharmadive
December 10, 2019
bitBiome, Inc. (Representative Director: Yoshihito Daimon, "bitBiome") and National Cancer Center of Japan (President...
-
Announcement of collaborative research agreement with National Cancer Center on analy sis of gut bacteria related to cancer
December 10, 2019
bitBiome, Inc. (Representative Director: Yoshihito Daimon, "bitBiome") and National Cancer Center of Japan (President...
-
Ping An Good Doctor and Merck Form Strategic Collaboration to Advance Intelligent Healthcare in China
biopharmadive
December 10, 2019
Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor"...
-
Blockchain technology in healthcare market to hit $1.6bn by 2025
europeanpharmaceuticalreview
September 16, 2019
According to a new report, blockchain technology in the healthcare market size is set to increase exponentially.
-
Colorcon, TruTag Technologies Partner on Authentication Technology
contractpharma
August 08, 2019
Combines TruTag’s silica-based microtag authentication technology with Colorcon’s expertise in film coating systems, modified release technologies, and specialty excipients.